Anti-Toxoplasma Activities of Zea Mays and Eryngium Caucasicum Extracts, In Vitro and In Vivo
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Toxoplasmosis is a worldwide health problem that caused by intracellular apicomplexan parasite, Toxoplasma gondii (T. gondii). Considering that the available drugs for toxoplasmosis have serious host toxicity, the aim of the current study was to survey the in vitro and in vivo anti-Toxoplasma activity of Zea mays (Z. mays) and Eryngium caucasicum (E. caucasicum) extracts. Methods: Four concentrations (5, 10, 25, and 50 mg mL -1 ) of Z. mays and E. caucasicum methanolic extracts for 30, 60, 120, and 180 min were incubated with infected macrophages and then the viability of RH strain of T. gondii tachyzoites was evaluated by trypan blue staining method. Also, we evaluated the survival rate of acutely infected mice with the extracts (100 and 200 mg kg -1 day -1 ) intraperitoneally for 5 days after infection with 2× 104tachyzoites of T. gondii. Results: The anti-Toxoplasma effect of the methanolic extracts were extremely significant compared to the negative control group in all exposure times (P < 0.05). The Z. mays (10, 25 and 50 mg mL -1 ) killed 100% of the parasites after 180 and 120 min exposure, respectively. Also, high toxoplasmacidal activity was observed with E. caucasicum extract. Furthermore, treatment of experimentally infected mice with the Z. mays (100, 200 mg kg -1 day -1 ) and E. caucasicum (100 mg kg -1 day -1 ) significantly increased their survival rate compared to untreated infected control (P < 0.05). Conclusion: These extracts are promising candidates for further medicine development on toxoplasmosis. However, further investigations are necessary to clarify effective fractions of the Z. mays and E. caucasicum extracts and the mechanisms of action.
Abstract
Objectives: Toxoplasmosis is a worldwide health problem that caused by intracellular apicomplexan parasite, Toxoplasma gondii (T. gondii). Considering that the available drugs for toxoplasmosis have serious host toxicity, the aim of the current study was to survey the in vitro and in vivo anti-Toxoplasma activity of Zea mays (Z. mays) and Eryngium caucasicum (E. caucasicum) extracts. Methods: Four concentrations (5, 10, 25, and 50 mg mL -1 ) of Z. mays and E. caucasicum methanolic extracts for 30, 60, 120, and 180 min were incubated with infected macrophages and then the viability of RH strain of T. gondii tachyzoites was evaluated by trypan blue staining method. Also, we evaluated the survival rate of acutely infected mice with the extracts (100 and 200 mg kg -1 day -1 ) intraperitoneally for 5 days after infection with 2× 104tachyzoites of T. gondii. Results: The anti-Toxoplasma effect of the methanolic extracts were extremely significant compared to the negative control group in all exposure times (P < 0.05). The Z. mays (10, 25 and 50 mg mL -1 ) killed 100% of the parasites after 180 and 120 min exposure, respectively. Also, high toxoplasmacidal activity was observed with E. caucasicum extract. Furthermore, treatment of experimentally infected mice with the Z. mays (100, 200 mg kg -1 day -1 ) and E. caucasicum (100 mg kg -1 day -1 ) significantly increased their survival rate compared to untreated infected control (P < 0.05). Conclusion: These extracts are promising candidates for further medicine development on toxoplasmosis. However, further investigations are necessary to clarify effective fractions of the Z. mays and E. caucasicum extracts and the mechanisms of action.
참고문헌 (37)
- Montoya JG, "Toxoplasmosis", Lancet, 363(9425), pp.1965~1976 (2004)
- Hoffmann S, "Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens", J Food Prot, 75(7), pp.1292~1302 (2012)
- Pappas G, "Toxoplasmosis snapshots : global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis", Int J Parasitol, 39(12), pp.1385~1394 (2009)
- Torgerson PR, "The global burden of congenital toxoplasmosis : a systematic review", Bull World Health Organ, 91(7), pp.501~508 (2013)
- Dubey J, "Toxoplasma gondii infection in humans and animals in the United States", Int J Parasitol, 38(11), pp.1257~1278 (2008)
- Ahmadpour E, "Toxoplasmosis in immunocompromised patients in Iran : a systematic review and meta-analysis", J Infect Dev Ctries, 8(12), pp.1503~1510 (2014)
- Montoya J, "Toxoplasmosis", The Lancet, 363(9425), pp.1965~1976 (2004)
- Rodriguez JB, "New antibacterials for the treatment of toxoplasmosis; a patent review", Expert Opin Ther Pat, 22(3), pp.311~333 (2012)
- Araujo FG, "Recent advances in the search for new drugs for treatment of toxoplasmosis", Int J Antimicrob Agents, 1(4), pp.153~164 (1992)
- Petersen E, "Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?", Expert Rev Anti Infect Ther., 1(1), pp.175~182 (2003)
- Serranti D, "Congenital toxoplasmosis treatment", Eur Rev Med Pharmacol Sci, 15(2), pp.193~198 (2011)
- Aspinall TV, "The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis", J Infect Dis, 185(11), pp.1637~1643 (2002)
- Ahmadpour E, "Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by Calcium Phosphate nanoparticles as an adjuvant", Immunol Lett, 185, pp.40~47 (2017)
- Ahmadpour E, "Evaluation of the immune response in BALB", c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii, 2017, pp.39(4), ~
- Montazeri M, "A Systematic Review of In Vitro and In Vivo Activities of Anti-Toxoplasma Drugs and Compounds(2006 to 2016)", Front Microbiol, 8, pp.25~ (2017)
- Newman DJ, "Natural products as sources of new drugs from 1981 to 2014", J Nat Prod, 79(3), pp.629~661 (2016)
- Sharif M, "Effect of methanolic extracts of Artemisia aucheri and Camellia sinensis on Leishmania major(in vitro)", Turk J Med Sci, 36(6), pp.365~369 (2007)
- Kayser O, "Natural products and synthetic compounds as immunomodulators", Expert Rev Anti Infect Ther, 1(2), pp.319~335 (2003)
- Newman DJ, "Natural products as sources of new drugs over the 30 years from 1981 to 2010", Nat Prod J, 75(3), pp.311~335 (2012)
- C Sepulveda-Arias J, "Anti-Toxoplasma activity of natural products : a review", Recent Pat Antiinfect Drug Discov, 9(3), pp.186~194 (2014)
- Choi K-M, "Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine", Int J Antimicrob Agents, 32(4), pp.360~362 (2008)
- Gholamreza Karimi, "Increase in the Th1-Cell-Based Immune Response in Healthy Workers Exposed to Low-Dose Radiation - Immune System Status of Radiology Staff", Journal of Pharmacopuncture, 20(2), pp.107~111 (2017), 대한약침학회
- Hasanudin K, "Corn silk(Stigma maydis)in healthcare : a phytochemical and pharmacological review", Molecules, 17(8), pp.9697~9715 (2012)
- Nabavi S, "Biological activities of flavonoid-rich fraction of Eryngium caucasicum Trautv", Eur Rev Med Pharmacol Sci, 16, pp.81~87 (2012)
- Ebrahimzadeh MA, "Antioxidant activity of leaves and inflorescence of Eryngium caucasicum Trautv at flowering stage", PharmacognosyRes, 1(6), pp.435~ (2009)
- Daryani A, "Anti-Toxoplasma activities of methanolic extract of Sambucus nigra(Caprifoliaceae)fruits and leaves", Rev biol trop, 63(1), pp.07~12 (2015)
- Akins CK, "Laboratory animals in research and teaching: Ethics, care, and methods" (2005), American Psychological Association
- Al-Zanbagi NA, "In vivo effect of some home spices extracts on the Toxoplasma gondii tachyzoites", J Family Community Med, 16(2), pp.59~ (2009)
- Khanam Z, "Phytochemical screening and antimicrobial activity of root and stem extracts of wild Eurycoma longifolia Jack(Tongkat Ali)", JKSUS, 27(1), pp.23~30 (2015)
- Kavitha N, "In vitro anti-Toxoplasma gondii activity of root extract", fractions of Eurycoma longifolia Jack, 2012, pp.12(1), 1~
- Pillai S, "Anti-parasitic activity of Myristica fragrans Houtt. essential oil against Toxoplasma gondii parasite", APCBEE Procedia, 2, pp.92~96 (2012)
- Leesombun A, "Effects of Extracts from Thai Piperaceae Plants against Infection with Toxoplasma gondii", PloS one, 11(5), pp.e0156116~ (2016)
- Zhang X, "Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo", Exp Parasitol, 165, pp.95~102 (2016)
- Doggett JS, "Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis", Proc Natl Acad Sci, 109(39), pp.15936~15941 (2012)
- Montazeri M, "Effect of propranolol alone and in combination with pyrimethamine on acute murine toxoplasmosis", Jundishapur J Microbiol, 8(9) (2015)
- Montazeri M, "Evaluation of Propranolol Effect on Experimental Acute and Chronic Toxoplasmosis using Q-PCR", Antimicrob Agents Chemother, 60(12), pp.7128~7133 (2016)
- Montazeri, M, "Survey on synergism effect of ketotifen in combination with pyrimethamine in treatment of acute murine toxoplasmosis", Trop Med Int, 45(1), pp.39~ (2017)
